Ahead Gene key facts
- Developer of synthetic biological technologies designed for applications in pharmaceuticals and chemical manufacturing.
- Notable investors include Sichuan Venture Capital, Sichuan Development Fund, Chengdu Bio-Town Investment, Chengdu Technology Groups.
- Status: Privately Held (backing).
- ·Watch Ahead Gene: the Monday email on marks, rounds and moves
Ahead Gene funding rounds
No funding rounds for Ahead Gene are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Ahead Gene investors
4 investors are on record for Ahead Gene, including Sichuan Venture Capital, Sichuan Development Fund, Chengdu Bio-Town Investment and Chengdu Technology Groups.
About Ahead Gene
Developer of synthetic biological technologies designed for applications in pharmaceuticals and chemical manufacturing. The company's platform focuses on the creation and application of non-natural protein functions, integrating research and development, production, and commercialization capabilities, enabling the biotechnology and chemical industries to access comprehensive solutions for the development and implementation of advanced synthetic biological products.
- Sector
- Healthcare
- HQ
- Chengdu, China
- Founded
- 2021
- Website
- aheadgene.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.
Ahead Gene doesn't have a valuation on record yet — one is published once a priced round, a reported valuation, fund marks, or secondary prints surface in our sources. The rest of the record below builds toward it.